197 related articles for article (PubMed ID: 28322944)
21. The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan.
Joseph KS; Hage DS
J Pharm Biomed Anal; 2010 Nov; 53(3):811-8. PubMed ID: 20537832
[TBL] [Abstract][Full Text] [Related]
22. Binding of tolbutamide to glycated human serum albumin.
Joseph KS; Anguizola J; Hage DS
J Pharm Biomed Anal; 2011 Jan; 54(2):426-32. PubMed ID: 20880646
[TBL] [Abstract][Full Text] [Related]
23. Recent topics in chemical and clinical research on glycated albumin.
Ueda Y; Matsumoto H
J Diabetes Sci Technol; 2015 Mar; 9(2):177-82. PubMed ID: 25614014
[TBL] [Abstract][Full Text] [Related]
24. Protective ability and binding affinity of captopril towards serum albumin in an in vitro glycation model of diabetes mellitus.
Mariee AD; Al-Shabanah O
J Pharm Biomed Anal; 2006 May; 41(2):571-5. PubMed ID: 16469467
[TBL] [Abstract][Full Text] [Related]
25. Comparison of modification sites formed on human serum albumin at various stages of glycation.
Barnaby OS; Cerny RL; Clarke W; Hage DS
Clin Chim Acta; 2011 Jan; 412(3-4):277-85. PubMed ID: 21034726
[TBL] [Abstract][Full Text] [Related]
26. Formation of the molten globule-like state during prolonged glycation of human serum albumin.
Sattarahmady N; Moosavi-Movahedi AA; Ahmad F; Hakimelahi GH; Habibi-Rezaei M; Saboury AA; Sheibani N
Biochim Biophys Acta; 2007 Jun; 1770(6):933-42. PubMed ID: 17368729
[TBL] [Abstract][Full Text] [Related]
27. An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus.
Neelofar K; Ahmad J
Glycoconj J; 2017 Oct; 34(5):575-584. PubMed ID: 28812216
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of vitamin B
Abdullah KM; Qais FA; Ahmad I; Naseem I
Arch Biochem Biophys; 2017 Aug; 627():21-29. PubMed ID: 28624351
[TBL] [Abstract][Full Text] [Related]
29. Hyperglycemia induced structural and functional changes in human serum albumin of diabetic patients: a physico-chemical study.
Neelofar K; Arif Z; Alam K; Ahmad J
Mol Biosyst; 2016 Jul; 12(8):2481-9. PubMed ID: 27226040
[TBL] [Abstract][Full Text] [Related]
30. Investigation of thermal reversibility and stability of glycated human serum albumin.
Bohlooli M; Moosavi-Movahedi AA; Taghavi F; Maghami P; Saboury AA; Moosavi-Movahedi Z; Farhadi M; Hong J; Sheibani N; Habibi-Rezaei M
Int J Biol Macromol; 2013 Nov; 62():358-64. PubMed ID: 24060284
[TBL] [Abstract][Full Text] [Related]
31. Mechanistic physicochemical insights into glycation and drug binding by serum albumin: Implications in diabetic conditions.
Ghosh R; Kishore N
Biochimie; 2022 Feb; 193():16-37. PubMed ID: 34688791
[TBL] [Abstract][Full Text] [Related]
32. Chromatographic analysis of acetohexamide binding to glycated human serum albumin.
Joseph KS; Anguizola J; Jackson AJ; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2775-81. PubMed ID: 20829128
[TBL] [Abstract][Full Text] [Related]
33. Unveiling the molecular basis of inflamm-aging induced by advanced glycation end products (AGEs)-modified human serum albumin (AGE-HSA) in patients with different immune-mediated diseases.
Shen CY; Li KJ; Wu CH; Lu CH; Kuo YM; Hsieh SC; Yu CL
Clin Immunol; 2023 Jul; 252():109655. PubMed ID: 37257547
[TBL] [Abstract][Full Text] [Related]
34. Mechanistic insight into glycation inhibition of human serum albumin by vitamin B9: Multispectroscopic and molecular docking approach.
Al Jaseem MAJ; Abdullah KM; Qais FA; Shamsi A; Naseem I
Int J Biol Macromol; 2021 Jun; 181():426-434. PubMed ID: 33775768
[TBL] [Abstract][Full Text] [Related]
35. Abundance matters: role of albumin in diabetes, a proteomics perspective.
Bhat S; Jagadeeshaprasad MG; Venkatasubramani V; Kulkarni MJ
Expert Rev Proteomics; 2017 Aug; 14(8):677-689. PubMed ID: 28689445
[TBL] [Abstract][Full Text] [Related]
36. Glycated Serum Albumin and AGE Receptors.
Vetter SW
Adv Clin Chem; 2015; 72():205-75. PubMed ID: 26471084
[TBL] [Abstract][Full Text] [Related]
37. The anti-apoptotic activity of albumin for endothelium is inhibited by advanced glycation end products restricting intramolecular movement.
Zoellner H; Siddiqui S; Kelly E; Medbury H
Cell Mol Biol Lett; 2009; 14(4):575-86. PubMed ID: 19484197
[TBL] [Abstract][Full Text] [Related]
38. Identification of the carboxymethyllysine residue in the advanced stage of glycated human serum albumin.
Takanashi M; Sakurai T; Tsuchiya S
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):705-8. PubMed ID: 1611683
[TBL] [Abstract][Full Text] [Related]
39. Probing nonenzymatic glycation of proteins by deep ultraviolet light emitting diode induced autofluorescence.
Mukunda DC; Joshi VK; Chandra S; Siddaramaiah M; Rodrigues J; Gadag S; Nayak UY; Mazumder N; Satyamoorthy K; Mahato KK
Int J Biol Macromol; 2022 Jul; 213():279-296. PubMed ID: 35654218
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of glycation patterns in human serum albumin using 16O/18O-labeling and MALDI-TOF MS.
Barnaby OS; Cerny RL; Clarke W; Hage DS
Clin Chim Acta; 2011 Aug; 412(17-18):1606-15. PubMed ID: 21601565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
